Results 211 to 220 of about 25,878 (248)
Some of the next articles are maybe not open access.
Anesthesia and Monoamine Oxidase Inhibitors
JAMA: The Journal of the American Medical Association, 1989To the Editor.— I wish to register my strong disagreement with your consultants Drs Hirshman and Lindeman 1 and their assertion that it is safe to administer an elective anesthetic to a patient receiving monoamine oxidase inhibitors. 1 I believe that theirs is a minority viewpoint.
openaire +2 more sources
Drugs & Aging, 1998
Monoamine oxidase inhibitors (MAOIs) are mainly used in psychiatry for the treatment of depressive disorders and in neurology for the treatment of Parkinson's disease. While the classical, nonselective and nonreversible MAOIs, such as phenelzine and tranylcypromine, are characterised by the risk of inducing a hypertensive crisis when dietary tyramine ...
H P, Volz, C H, Gleiter
openaire +4 more sources
Monoamine oxidase inhibitors (MAOIs) are mainly used in psychiatry for the treatment of depressive disorders and in neurology for the treatment of Parkinson's disease. While the classical, nonselective and nonreversible MAOIs, such as phenelzine and tranylcypromine, are characterised by the risk of inducing a hypertensive crisis when dietary tyramine ...
H P, Volz, C H, Gleiter
openaire +4 more sources
Abuse of Monoamine Oxidase Inhibitors
The American Journal of Drug and Alcohol Abuse, 1992Monoamine oxidase inhibitors, like other antidepressants, generally are considered free of risk for abuse. There is, however, some evidence that MAOIs possess dependence and abuse potential for some patients. We will review the available literature and describe three current cases. Recommendations for treatment are discussed briefly.
G, Baumbacher, M S, Hansen
openaire +2 more sources
Styrylquinazolones as monoamine oxidase inhibitors
Pharmacological Research Communications, 1977Abstract Several substituted styrylquinazolones were synthesized and tested for their ability to inhibit the oxidative deamination of kynuramine by monoamine oxidase (MAO) from the rat brain. Quinazolones having hydrazide group were found to be better inhibitors than their corresponding precursor esters.
R S, Misra +4 more
openaire +2 more sources
Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase
Biochemical Pharmacology, 1960Abstract The effect of several monoamine oxidase (MAO) inhibitors and related compounds on guinea pig liver MAO and diamine oxidase (DAO) was examined in vitro and after administration to animals. The results showed that the MAO inhibitors possessing the hydrazine moiety inhibited both MAO and DAO, while two phenyl cyclo propylamine MAO inhibitors ...
P A, SHORE, V H, COHN
openaire +2 more sources
Anesthesia & Analgesia, 1985
Adverse cardiovascular responses to anesthesia during either electroconvulsive therapy (ECT) or elective surgical procedures were evaluated in 27 patients maintained on chronic (3 months-3 yr) monoamine oxidase inhibitor (MAOI) therapy. Changes in blood pressure and heart rate in study patients (n = 22 ECTs in 13 patients) undergoing ECT were not ...
A R, el-Ganzouri +3 more
openaire +2 more sources
Adverse cardiovascular responses to anesthesia during either electroconvulsive therapy (ECT) or elective surgical procedures were evaluated in 27 patients maintained on chronic (3 months-3 yr) monoamine oxidase inhibitor (MAOI) therapy. Changes in blood pressure and heart rate in study patients (n = 22 ECTs in 13 patients) undergoing ECT were not ...
A R, el-Ganzouri +3 more
openaire +2 more sources
Monoamine Oxidase Inhibitors and Neuroprotection
American Journal of Therapeutics, 2012Monoamine oxidase inhibitors have been available for more than 50 years, initially developed as antidepressants but currently used in a variety of psychiatric and neurological conditions. There has been a recent surge of interest in monoamine oxidase inhibitors because of their reported neuroprotective and/or neurorescue properties.
Saleem K, Al-Nuaimi +2 more
openaire +2 more sources